Evidence map›Paper›PMID 20176001›Full record

ArticleBrain research2010

Expression of hyaluronan and the hyaluronan-binding proteoglycans neurocan, aggrecan, and versican by neural stem cells and neural cells derived from embryonic stem cells.

Mary Abaskharoun, Marie Bellemare, Elizabeth Lau, Richard U Margolis

Open access · greenAbstract read
In one paragraph

Article in Brain research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Hyaluronan, a double-edged sword in kidney diseases.Pediatric nephrology (Berlin, Germany) · 2022
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Matrix regulators in neural stem cell functions.Biochimica et biophysica acta · 2014
    Review
  12. Review
  13. Extracellular matrix: functions in the nervous system.Cold Spring Harbor perspectives in biology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mary AbaskharounDepartment of Pharmacology, New York University Medical Center, 550 First Avenue, New York, NY 10016, USA.
Marie Bellemare
Elizabeth Lau
Richard U Margolis
Columbia University Irving Medical Center · USNew York University · US

Funding

Matrix components and stem cells in the aging brainR21AG024969 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARGOLIS, RICHARD U · 2004 to 2005
$372k
Neural Stem Cell ProteoglycansR03AG022590 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARGOLIS, RICHARD U · 2003 to 2003
$85k
NIA NIH HHS AG022590NIA NIH HHS AG024969NIA NIH HHS R03 AG022590NIA NIH HHS R21 AG024969
6 · The paper itself

Abstract

We have examined the expression and localization patterns of hyaluronan and hyaluronan-binding chondroitin sulfate proteoglycans in neural stem cells and differentiated neural cells derived from mouse embryonic stem cells. Expression of proteoglycans and hyaluronan was weak in the SSEA1-positive embryonic stem cells but increased noticeably after retinoic acid induction to nestin-positive neural stem cells. After subsequent plating, the hyaluronan-binding chondroitin sulfate proteoglycans aggrecan, neurocan, and versican are expressed by cells in both the astrocytic and neuronal lineages. During the time period that hyaluronan was present, it co-localized with each of the hyaluronan-binding proteoglycans studied and was found to be clearly associated with beta-III tubulin-expressing neurons and oligodendrocytes expressing the O4 sulfatide marker. Although proteoglycan expression levels increased to varying degrees following neural differentiation, they did not change noticably during the following 2 weeks in culture, but there was a significant decrease in hyaluronan expression. Our studies therefore demonstrate the expression by neural stem cells and neural cells derived from them of hyaluronan and its associated proteoglycans, thereby providing a necessary foundation for integrating their specific properties into developing strategies for therapeutic applications.

Indexed as

AggrecansAnimalsAntineoplastic AgentsCells, CulturedEmbryo, MammalianEmbryonic Stem CellsGreen Fluorescent ProteinsHumansHyaluronic AcidMiceNerve Tissue ProteinsNeurocanNeuronsProteoglycansTransfectionTretinoinAggrecansAntineoplastic AgentsGreen Fluorescent ProteinsHyaluronic AcidNcan protein, mouseNerve Tissue ProteinsNeurocanProteoglycansTretinoinVersicans

Identifiers

PMID20176001
PMCPMC2878141
OpenAlexW1974173409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.